arrow_back Trending Legislation
Share share

Pandemic Research: New Medicines and Medical Technologies

This law aims to accelerate research into new medicines and medical technologies to combat viruses with pandemic potential. This means we will be better prepared for future health threats, potentially leading to faster access to vaccines and treatments during a crisis.
Key points
Establishing or continuing research programs for medical products and technologies against pandemic viruses.
Funding research centers to develop new medical products and identify existing drugs to combat viruses.
Improved coordination among various federal agencies regarding public health threat research.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
Print number: S 3489
Sponsor: Sen. Burr, Richard [R-NC]
Process start date: 2022-01-12
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Pandemic Research: New Medicines and Medical Technologies

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 3489.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-01-12.

What are the main provisions?

Key points include:

  • Establishing or continuing research programs for medical products and technologies against pandemic viruses.
  • Funding research centers to develop new medical products and identify existing drugs to combat viruses.
  • Improved coordination among various federal agencies regarding public health threat research.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Burr, Richard [R-NC].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 3489

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Public Investments